BNTX logo

BioNTech SE (BNTX) Cash From Investing

Annual CFI:

-$2.25B+$5.27B(+70.06%)
December 31, 2024

Summary

  • As of today, BNTX annual cash from investing is -$2.25 billion, with the most recent change of +$5.27 billion (+70.06%) on December 31, 2024.
  • During the last 3 years, BNTX annual cash from investing has fallen by -$1.58 billion (-236.44%).
  • BNTX annual cash from investing is now -5968.06% below its all-time high of -$37.10 million, reached on December 31, 2022.

Performance

BNTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Quarterly CFI:

-$26.67M-$1.34B(-102.03%)
June 30, 2025

Summary

  • As of today, BNTX quarterly cash from investing is -$26.67 million, with the most recent change of -$1.34 billion (-102.03%) on June 30, 2025.
  • Over the past year, BNTX quarterly cash from investing has increased by +$222.17 million (+89.28%).
  • BNTX quarterly cash from investing is now -102.03% below its all-time high of $1.31 billion, reached on March 31, 2025.

Performance

BNTX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

TTM CFI:

$1.77B+$222.17M(+14.33%)
June 30, 2025

Summary

  • As of today, BNTX TTM cash from investing is $1.77 billion, with the most recent change of +$222.17 million (+14.33%) on June 30, 2025.
  • Over the past year, BNTX TTM cash from investing has increased by +$8.71 billion (+125.54%).
  • BNTX TTM cash from investing is now at all-time high.

Performance

BNTX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BNTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+70.1%+89.3%+125.5%
3Y3 Years-236.4%+71.5%+577.8%
5Y5 Years-2508.3%-151.3%+2950.2%

BNTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-5968.1%+70.1%-102.0%+99.1%at high+119.3%
5Y5-Year-5968.1%+70.1%-102.0%+99.1%at high+119.3%
All-TimeAll-Time-5968.1%+70.1%-102.0%+99.1%at high+119.3%

BNTX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$26.67M(-102.0%)
$1.77B(+14.3%)
Mar 2025
-
$1.31B(+102.1%)
$1.55B(+168.5%)
Dec 2024
-$2.25B(+70.1%)
$649.24M(+499.2%)
-$2.26B(+60.6%)
Sep 2024
-
-$162.62M(+34.6%)
-$5.75B(+17.2%)
Jun 2024
-
-$248.84M(+90.1%)
-$6.94B(+24.4%)
Mar 2024
-
-$2.50B(+11.8%)
-$9.18B(-22.9%)
Dec 2023
-$7.52B(>-9900.0%)
-$2.84B(-109.5%)
-$7.47B(-55.5%)
Sep 2023
-
-$1.35B(+45.7%)
-$4.80B(-35.5%)
Jun 2023
-
-$2.49B(-215.8%)
-$3.55B(-208.8%)
Mar 2023
-
-$789.04M(-362.4%)
-$1.15B(-3018.8%)
Dec 2022
-$37.10M(+94.5%)
-$170.65M(-79.4%)
-$36.82M(+91.2%)
Sep 2022
-
-$95.09M(-1.7%)
-$417.24M(-12.5%)
Jun 2022
-
-$93.49M(-129.0%)
-$370.94M(-18.4%)
Mar 2022
-
$322.41M(+158.5%)
-$313.33M(+53.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$669.12M(-305.2%)
-$551.06M(-1029.3%)
-$669.83M(-185.9%)
Sep 2021
-
-$48.80M(-36.0%)
-$234.31M(-12.2%)
Jun 2021
-
-$35.88M(-5.3%)
-$208.74M(-13.8%)
Mar 2021
-
-$34.09M(+70.5%)
-$183.48M(-10.6%)
Dec 2020
-$165.12M(-91.3%)
-$115.54M(-397.3%)
-$165.84M(-166.7%)
Sep 2020
-
-$23.24M(-118.9%)
-$62.18M(-0.2%)
Jun 2020
-
-$10.61M(+35.5%)
-$62.08M(+4.8%)
Mar 2020
-
-$16.45M(-38.5%)
-$65.20M(+24.6%)
Dec 2019
-$86.31M(-9.0%)
-$11.88M(+48.7%)
-$86.43M(-15.9%)
Sep 2019
-
-$23.14M(-68.4%)
-$74.55M(-45.0%)
Jun 2019
-
-$13.74M(+63.5%)
-$51.41M(-36.5%)
Mar 2019
-
-$37.68M
-$37.68M
Dec 2018
-$79.22M(-33.7%)
-
-
Dec 2017
-$59.27M
-
-

FAQ

  • What is BioNTech SE annual cash from investing?
  • What is the all-time high annual cash from investing for BioNTech SE?
  • What is BioNTech SE annual cash from investing year-on-year change?
  • What is BioNTech SE quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for BioNTech SE?
  • What is BioNTech SE quarterly cash from investing year-on-year change?
  • What is BioNTech SE TTM cash from investing?
  • What is the all-time high TTM cash from investing for BioNTech SE?
  • What is BioNTech SE TTM cash from investing year-on-year change?

What is BioNTech SE annual cash from investing?

The current annual cash from investing of BNTX is -$2.25B

What is the all-time high annual cash from investing for BioNTech SE?

BioNTech SE all-time high annual cash from investing is -$37.10M

What is BioNTech SE annual cash from investing year-on-year change?

Over the past year, BNTX annual cash from investing has changed by +$5.27B (+70.06%)

What is BioNTech SE quarterly cash from investing?

The current quarterly cash from investing of BNTX is -$26.67M

What is the all-time high quarterly cash from investing for BioNTech SE?

BioNTech SE all-time high quarterly cash from investing is $1.31B

What is BioNTech SE quarterly cash from investing year-on-year change?

Over the past year, BNTX quarterly cash from investing has changed by +$222.17M (+89.28%)

What is BioNTech SE TTM cash from investing?

The current TTM cash from investing of BNTX is $1.77B

What is the all-time high TTM cash from investing for BioNTech SE?

BioNTech SE all-time high TTM cash from investing is $1.77B

What is BioNTech SE TTM cash from investing year-on-year change?

Over the past year, BNTX TTM cash from investing has changed by +$8.71B (+125.54%)
On this page